Skip to Content

L'Oreal SA

OR: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€734.00LbdhVwgbbfjx

L’Oreal: Solid Beauty Demand, Innovation, and Tight Channel Ties To Fuel Top Line; Shares Overvalued

We are raising our fair value estimate for L’Oreal to EUR 376 (from EUR 336), which implies a 31 times multiple against our 2024 earnings estimate. The increase is driven by higher annual sales growth assumptions (7.0% versus 6.2% in the prior model), alongside faster growth (7% versus 6% previously) in earnings before interest (excluding tax) in the decade following the 10-year explicit forecast period. That said, we view L’Oreal shares as slightly overvalued, trading at an 8% premium to our intrinsic valuation, and would wait for a better risk/reward opportunity before building a position in this name.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of OR so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center